|
Relative bioavailability of H3B-6545 tablets versus capsules and drug-drug interaction between H3B-6545 and pantoprazole. |
| |
|
Employment - H3 Biomedicine; Novartis |
Stock and Other Ownership Interests - Novartis |
Patents, Royalties, Other Intellectual Property - H3 Biomedicine |
| |
|
|
Stock and Other Ownership Interests - LabCorp |
Research Funding - Covance |
| |
|
Leadership - Context Therapeutics |
Stock and Other Ownership Interests - Humanigen; Pfizer |
Travel, Accommodations, Expenses - H3 Biomedicine |
| |
|
|
Stock and Other Ownership Interests - Eisai; Vertex |
Research Funding - Eisai; Vertex |
| |
|
Employment - Eisai Europe |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - H3 Biomedicine |
Leadership - H3 Biomedicine |
Patents, Royalties, Other Intellectual Property - H3 Biomedicine |